Neuren Pharmaceuticals LimitedASX: NEU

DAYBUE (trofinetide) launched in US - Neuren earns US$40m

Apr 18, 2023 at 4:11 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment